© Donald Weber/Atlas Press
Learn how the current model of R&D is failing patients in the developing world and MSF's work to support alternative models.
We continue to highlight where research & development is needed to address urgent health needs in places where MSF works and to analyse and promote new models of innovation that benefit those most in need.

In just 10 years the Drugs for Neglected Diseases initiative (DNDi) has delivered six new treatments for four neglected diseases. On DNDi's anniversary, MSF reflects on its role in founding the initiative, DNDi's successes, and what challenges await DNDi in the future. » READ MORE

© Donald Weber/Atlas Press
Learn how the current model of R&D is failing patients in the developing world and MSF's work to support alternative models.

Niger 2009 © Olivier Asselin
Find out more about how MSF has piloted innovative ways to increase our capacity for rapid response in the often challenging situations where we operate.
Because very few children are infected with HIV in rich countries pharmaceutical companies have no commercial incentive to develop drugs or tests that will work for children